Cyclophosphamide
Locally Advanced Cervical Carcinoma
City of Hope Medical CenterSmall moleculePhase 1/2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 44/ 100
- Competitive Position
- 95/ 100
Competitive context
60 Active assets in the Locally Advanced Cervical Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin Advenchen Laboratories, LLC | Phase 3 | BB |
Gardasil 9 Vaccine Eunice Dube | Phase 4 | BB |
Hepatitis B Virus Vaccine Eunice Dube | Phase 4 | BB |
Pembrolizumab Mayo Clinic | Phase 2 | BB |
Hycamtin Advenchen Laboratories, LLC | Phase 3 | BB |
View all 50 →
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →